SG Americas Securities’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-43,028
| Closed | -$13K | – | 2957 |
|
|
2025
Q1 | $13K | Buy |
43,028
+5,392
| +14% | +$1.63K | ﹤0.01% | 2971 |
|
|
2024
Q4 | $35K | Buy |
37,636
+17,172
| +84% | +$16K | ﹤0.01% | 2613 |
|
|
2024
Q3 | $24K | Buy |
+20,464
| New | +$24K | ﹤0.01% | 2928 |
|
|
2024
Q2 | – | Sell |
-35,938
| Closed | -$110K | – | 2729 |
|
|
2024
Q1 | $110K | Sell |
35,938
-3,854
| -10% | -$11.8K | ﹤0.01% | 2207 |
|
|
2023
Q4 | $128K | Buy |
39,792
+13,728
| +53% | +$44.2K | ﹤0.01% | 2333 |
|
|
2023
Q3 | $100K | Buy |
+26,064
| New | +$100K | ﹤0.01% | 2530 |
|
|
2020
Q3 | – | Sell |
-23,422
| Closed | -$173K | – | 2697 |
|
|
2020
Q2 | $173K | Buy |
+23,422
| New | +$173K | ﹤0.01% | 2566 |
|
|
2019
Q1 | – | Sell |
-18,870
| Closed | -$46K | – | 2936 |
|
|
2018
Q4 | $46K | Buy |
+18,870
| New | +$46K | ﹤0.01% | 2386 |
|